ReP USP - Resultado da busca

Artigo de periodico
Pharmacogenomics of mycophenolic acid in kidney transplantation: Contribution of immune response-related genes (2022)
Hirata, Rosario Dominguez Crespo ; Genvigir, Fabiana Dalla Vecchia ; Hirata, Thiago Dominguez Crespo ; Cerda, Alvaro ; Hirata, Mario Hiroyuki
Source: Brazilian Journal of Pharmaceutical Sciences. Unidade: FCF
Subjects: TRANSPLANTE DE RIM, FÁRMACOS IMUNOSSUPRESSORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HIRATA, Rosario Dominguez Crespo et al. Pharmacogenomics of mycophenolic acid in kidney transplantation: Contribution of immune response-related genes. Brazilian Journal of Pharmaceutical Sciences, v. 58, p. 1-22 art. e201188, 2022Tradução . . Disponível em: https://doi.org/10.1590/s2175-97902022e201188. Acesso em: 16 jun. 2024.
APA
Hirata, R. D. C., Genvigir, F. D. V., Hirata, T. D. C., Cerda, A., & Hirata, M. H. (2022). Pharmacogenomics of mycophenolic acid in kidney transplantation: Contribution of immune response-related genes. Brazilian Journal of Pharmaceutical Sciences, 58, 1-22 art. e201188. doi:10.1590/s2175-97902022e201188
NLM
Hirata RDC, Genvigir FDV, Hirata TDC, Cerda A, Hirata MH. Pharmacogenomics of mycophenolic acid in kidney transplantation: Contribution of immune response-related genes [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2022 ; 58 1-22 art. e201188.[citado 2024 jun. 16 ] Available from: https://doi.org/10.1590/s2175-97902022e201188
Vancouver
Hirata RDC, Genvigir FDV, Hirata TDC, Cerda A, Hirata MH. Pharmacogenomics of mycophenolic acid in kidney transplantation: Contribution of immune response-related genes [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2022 ; 58 1-22 art. e201188.[citado 2024 jun. 16 ] Available from: https://doi.org/10.1590/s2175-97902022e201188
Trabalho de evento-resumo periodico
MicroRNAs as possible biomarker of nephrotoxicity induced by cisplatin in patients with head and neck cancer (2019)
Quintanilha, Júlia Coelho de França; Cobaxo, Thiago Sereno; Cursino, Maria Aparecida; Borges, Jéssica Bassani ; Vasconcelos, Pedro Eduardo Nascimento Silva ; Torso, Nadine de Godoy; Bastos, Larissa Brito; Hirata, Mario Hiroyuki ; Lima, Carmen Silvia Passos; Moriel, Patricia
Source: Brazilian Journal of Pharmaceutical Sciences. Conference titles: Pharmaceutical Congress of São Paulo. Unidade: FCF
Subjects: BIOMARCADORES, QUIMIOTERÁPICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
QUINTANILHA, Júlia Coelho de França et al. MicroRNAs as possible biomarker of nephrotoxicity induced by cisplatin in patients with head and neck cancer. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. Disponível em: http://scielousp.webhostusp.sti.usp.br/wp-content/uploads/2020/03/Anais-XXCongressodeFarmaciaSP-BJPS-final2.pdf. Acesso em: 16 jun. 2024. , 2019
APA
Quintanilha, J. C. de F., Cobaxo, T. S., Cursino, M. A., Borges, J. B., Vasconcelos, P. E. N. S., Torso, N. de G., et al. (2019). MicroRNAs as possible biomarker of nephrotoxicity induced by cisplatin in patients with head and neck cancer. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. Recuperado de http://scielousp.webhostusp.sti.usp.br/wp-content/uploads/2020/03/Anais-XXCongressodeFarmaciaSP-BJPS-final2.pdf
NLM
Quintanilha JC de F, Cobaxo TS, Cursino MA, Borges JB, Vasconcelos PENS, Torso N de G, Bastos LB, Hirata MH, Lima CSP, Moriel P. MicroRNAs as possible biomarker of nephrotoxicity induced by cisplatin in patients with head and neck cancer [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2019 ; 120 res. CFSP239.[citado 2024 jun. 16 ] Available from: http://scielousp.webhostusp.sti.usp.br/wp-content/uploads/2020/03/Anais-XXCongressodeFarmaciaSP-BJPS-final2.pdf
Vancouver
Quintanilha JC de F, Cobaxo TS, Cursino MA, Borges JB, Vasconcelos PENS, Torso N de G, Bastos LB, Hirata MH, Lima CSP, Moriel P. MicroRNAs as possible biomarker of nephrotoxicity induced by cisplatin in patients with head and neck cancer [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2019 ; 120 res. CFSP239.[citado 2024 jun. 16 ] Available from: http://scielousp.webhostusp.sti.usp.br/wp-content/uploads/2020/03/Anais-XXCongressodeFarmaciaSP-BJPS-final2.pdf
Trabalho de evento-resumo periodico
CYP3A5 and ABCB1 polymorphisms influence tracrolimus exposure in Brazilian and Spanish kidney transplant recipients (2019)
Genvigir, Fabiana Dalla Vecchia; Campos-Salazar, Antony Brayan ; Felipe, Claudia Rosso ; Silva Junior, Helio Tedesco ; Pestana, José Osmar Medina ; Hirata, Mario Hiroyuki ; Oliveira, Gladys; Herrero, María José; Pellicer, Salvador Francisco Aliño; Hirata, Rosario Dominguez Crespo
Source: Brazilian Journal of Pharmaceutical Sciences. Conference titles: Pharmaceutical Congress of São Paulo. Unidade: FCF
Subjects: POLIMORFISMO, BIOTRANSFORMAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GENVIGIR, Fabiana Dalla Vecchia et al. CYP3A5 and ABCB1 polymorphisms influence tracrolimus exposure in Brazilian and Spanish kidney transplant recipients. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. Disponível em: http://scielousp.webhostusp.sti.usp.br/wp-content/uploads/2020/03/Anais-XXCongressodeFarmaciaSP-BJPS-final2.pdf. Acesso em: 16 jun. 2024. , 2019
APA
Genvigir, F. D. V., Campos-Salazar, A. B., Felipe, C. R., Silva Junior, H. T., Pestana, J. O. M., Hirata, M. H., et al. (2019). CYP3A5 and ABCB1 polymorphisms influence tracrolimus exposure in Brazilian and Spanish kidney transplant recipients. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. Recuperado de http://scielousp.webhostusp.sti.usp.br/wp-content/uploads/2020/03/Anais-XXCongressodeFarmaciaSP-BJPS-final2.pdf
NLM
Genvigir FDV, Campos-Salazar AB, Felipe CR, Silva Junior HT, Pestana JOM, Hirata MH, Oliveira G, Herrero MJ, Pellicer SFA, Hirata RDC. CYP3A5 and ABCB1 polymorphisms influence tracrolimus exposure in Brazilian and Spanish kidney transplant recipients [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2019 ; 39 res. CFSP078.[citado 2024 jun. 16 ] Available from: http://scielousp.webhostusp.sti.usp.br/wp-content/uploads/2020/03/Anais-XXCongressodeFarmaciaSP-BJPS-final2.pdf
Vancouver
Genvigir FDV, Campos-Salazar AB, Felipe CR, Silva Junior HT, Pestana JOM, Hirata MH, Oliveira G, Herrero MJ, Pellicer SFA, Hirata RDC. CYP3A5 and ABCB1 polymorphisms influence tracrolimus exposure in Brazilian and Spanish kidney transplant recipients [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2019 ; 39 res. CFSP078.[citado 2024 jun. 16 ] Available from: http://scielousp.webhostusp.sti.usp.br/wp-content/uploads/2020/03/Anais-XXCongressodeFarmaciaSP-BJPS-final2.pdf
Trabalho de evento-resumo periodico
Tacrolimus-based therapy modifies the expression of microRNAs in urinary exosome of kidney transplant recipients (2019)
Bortolin, Raul Hernandes ; Freitas, Renata Caroline Costa de ; Genvigir, Fabiana Dalla Vecchia; Bonezi, Vivian; Felipe, Claudia Rosso ; Silva Junior, Helio Tedesco ; Pestana, José Osmar Medina ; Cerda, Alvaro; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Source: Brazilian Journal of Pharmaceutical Sciences. Conference titles: Pharmaceutical Congress of São Paulo. Unidade: FCF
Subjects: EXPRESSÃO GÊNICA, MICRORNAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BORTOLIN, Raul Hernandes et al. Tacrolimus-based therapy modifies the expression of microRNAs in urinary exosome of kidney transplant recipients. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. Disponível em: http://scielousp.webhostusp.sti.usp.br/wp-content/uploads/2020/03/Anais-XXCongressodeFarmaciaSP-BJPS-final2.pdf. Acesso em: 16 jun. 2024. , 2019
APA
Bortolin, R. H., Freitas, R. C. C. de, Genvigir, F. D. V., Bonezi, V., Felipe, C. R., Silva Junior, H. T., et al. (2019). Tacrolimus-based therapy modifies the expression of microRNAs in urinary exosome of kidney transplant recipients. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. Recuperado de http://scielousp.webhostusp.sti.usp.br/wp-content/uploads/2020/03/Anais-XXCongressodeFarmaciaSP-BJPS-final2.pdf
NLM
Bortolin RH, Freitas RCC de, Genvigir FDV, Bonezi V, Felipe CR, Silva Junior HT, Pestana JOM, Cerda A, Hirata MH, Hirata RDC. Tacrolimus-based therapy modifies the expression of microRNAs in urinary exosome of kidney transplant recipients [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2019 ; 186 res. CFSP372.[citado 2024 jun. 16 ] Available from: http://scielousp.webhostusp.sti.usp.br/wp-content/uploads/2020/03/Anais-XXCongressodeFarmaciaSP-BJPS-final2.pdf
Vancouver
Bortolin RH, Freitas RCC de, Genvigir FDV, Bonezi V, Felipe CR, Silva Junior HT, Pestana JOM, Cerda A, Hirata MH, Hirata RDC. Tacrolimus-based therapy modifies the expression of microRNAs in urinary exosome of kidney transplant recipients [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2019 ; 186 res. CFSP372.[citado 2024 jun. 16 ] Available from: http://scielousp.webhostusp.sti.usp.br/wp-content/uploads/2020/03/Anais-XXCongressodeFarmaciaSP-BJPS-final2.pdf
Trabalho de evento-resumo periodico
Characterization of the adipogenic protein E4orf1 of adenovirus 36 through molecular modeling techniques (2019)
Gutierrez, Alvaro; Ferreira, Glaucio Monteiro ; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo ; Cerda, Alvaro
Source: Brazilian Journal of Pharmaceutical Sciences. Conference titles: Pharmaceutical Congress of São Paulo. Unidade: FCF
Subjects: OBESIDADE, MODELAGEM MOLECULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GUTIERREZ, Alvaro et al. Characterization of the adipogenic protein E4orf1 of adenovirus 36 through molecular modeling techniques. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. Disponível em: http://scielousp.webhostusp.sti.usp.br/wp-content/uploads/2020/03/Anais-XXCongressodeFarmaciaSP-BJPS-final2.pdf. Acesso em: 16 jun. 2024. , 2019
APA
Gutierrez, A., Ferreira, G. M., Hirata, M. H., Hirata, R. D. C., & Cerda, A. (2019). Characterization of the adipogenic protein E4orf1 of adenovirus 36 through molecular modeling techniques. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. Recuperado de http://scielousp.webhostusp.sti.usp.br/wp-content/uploads/2020/03/Anais-XXCongressodeFarmaciaSP-BJPS-final2.pdf
NLM
Gutierrez A, Ferreira GM, Hirata MH, Hirata RDC, Cerda A. Characterization of the adipogenic protein E4orf1 of adenovirus 36 through molecular modeling techniques [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2019 ; 29 res. CFSP057.[citado 2024 jun. 16 ] Available from: http://scielousp.webhostusp.sti.usp.br/wp-content/uploads/2020/03/Anais-XXCongressodeFarmaciaSP-BJPS-final2.pdf
Vancouver
Gutierrez A, Ferreira GM, Hirata MH, Hirata RDC, Cerda A. Characterization of the adipogenic protein E4orf1 of adenovirus 36 through molecular modeling techniques [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2019 ; 29 res. CFSP057.[citado 2024 jun. 16 ] Available from: http://scielousp.webhostusp.sti.usp.br/wp-content/uploads/2020/03/Anais-XXCongressodeFarmaciaSP-BJPS-final2.pdf
Trabalho de evento-resumo periodico
Influence of polymorphisms LEP c.-2548A>G and LEPR c.668A>G on metabolic alterations in a pediatric population of southern Chile (2019)
Brito, Roberto; Manriquez, Victor; Sapunar, Jorge; Aguilar, Nicolas; Chandia, Damian; Navarro, Juan; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo ; Cerda, Alvaro
Source: Brazilian Journal of Pharmaceutical Sciences. Conference titles: Pharmaceutical Congress of São Paulo. Unidade: FCF
Subjects: POLIMORFISMO, OBESIDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BRITO, Roberto et al. Influence of polymorphisms LEP c.-2548A>G and LEPR c.668A>G on metabolic alterations in a pediatric population of southern Chile. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. Disponível em: http://scielousp.webhostusp.sti.usp.br/wp-content/uploads/2020/03/Anais-XXCongressodeFarmaciaSP-BJPS-final2.pdf. Acesso em: 16 jun. 2024. , 2019
APA
Brito, R., Manriquez, V., Sapunar, J., Aguilar, N., Chandia, D., Navarro, J., et al. (2019). Influence of polymorphisms LEP c.-2548A>G and LEPR c.668A>G on metabolic alterations in a pediatric population of southern Chile. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. Recuperado de http://scielousp.webhostusp.sti.usp.br/wp-content/uploads/2020/03/Anais-XXCongressodeFarmaciaSP-BJPS-final2.pdf
NLM
Brito R, Manriquez V, Sapunar J, Aguilar N, Chandia D, Navarro J, Hirata MH, Hirata RDC, Cerda A. Influence of polymorphisms LEP c.-2548A>G and LEPR c.668A>G on metabolic alterations in a pediatric population of southern Chile [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2019 ; 106 res. CFSP211.[citado 2024 jun. 16 ] Available from: http://scielousp.webhostusp.sti.usp.br/wp-content/uploads/2020/03/Anais-XXCongressodeFarmaciaSP-BJPS-final2.pdf
Vancouver
Brito R, Manriquez V, Sapunar J, Aguilar N, Chandia D, Navarro J, Hirata MH, Hirata RDC, Cerda A. Influence of polymorphisms LEP c.-2548A>G and LEPR c.668A>G on metabolic alterations in a pediatric population of southern Chile [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2019 ; 106 res. CFSP211.[citado 2024 jun. 16 ] Available from: http://scielousp.webhostusp.sti.usp.br/wp-content/uploads/2020/03/Anais-XXCongressodeFarmaciaSP-BJPS-final2.pdf
Artigo de periodico
Molecular characterization of Mycobacterium tuberculosis and Mycobacterium bovis isolates by Enterobacterial Repetitive Intergenic Consensus-PCR (2018)
Ferracioli, Katiany Rizzieri Caleffi; Baldin, Vanessa Pietrowski; Noguti, Erika Noda; Siqueira, Vera Lúcia Dias; Scodro, Regiane Bertin Lima; Pavan, Fernando Rogerio; Hirata, Mario Hiroyuki ; Cardoso, Rosilene Fressatti
Source: Brazilian Journal of Pharmaceutical Sciences. Unidade: FCF
Subjects: TUBERCULOSE, MYCOBACTERIUM TUBERCULOSIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERRACIOLI, Katiany Rizzieri Caleffi et al. Molecular characterization of Mycobacterium tuberculosis and Mycobacterium bovis isolates by Enterobacterial Repetitive Intergenic Consensus-PCR. Brazilian Journal of Pharmaceutical Sciences, v. 54, n. 3, p. 1-7 art. e17554, 2018Tradução . . Disponível em: https://doi.org/10.1590/s2175-97902018000317554. Acesso em: 16 jun. 2024.
APA
Ferracioli, K. R. C., Baldin, V. P., Noguti, E. N., Siqueira, V. L. D., Scodro, R. B. L., Pavan, F. R., et al. (2018). Molecular characterization of Mycobacterium tuberculosis and Mycobacterium bovis isolates by Enterobacterial Repetitive Intergenic Consensus-PCR. Brazilian Journal of Pharmaceutical Sciences, 54( 3), 1-7 art. e17554. doi:10.1590/s2175-97902018000317554
NLM
Ferracioli KRC, Baldin VP, Noguti EN, Siqueira VLD, Scodro RBL, Pavan FR, Hirata MH, Cardoso RF. Molecular characterization of Mycobacterium tuberculosis and Mycobacterium bovis isolates by Enterobacterial Repetitive Intergenic Consensus-PCR [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2018 ; 54( 3): 1-7 art. e17554.[citado 2024 jun. 16 ] Available from: https://doi.org/10.1590/s2175-97902018000317554
Vancouver
Ferracioli KRC, Baldin VP, Noguti EN, Siqueira VLD, Scodro RBL, Pavan FR, Hirata MH, Cardoso RF. Molecular characterization of Mycobacterium tuberculosis and Mycobacterium bovis isolates by Enterobacterial Repetitive Intergenic Consensus-PCR [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2018 ; 54( 3): 1-7 art. e17554.[citado 2024 jun. 16 ] Available from: https://doi.org/10.1590/s2175-97902018000317554
Artigo de periodico
Pharmacogenetic implications in the management of metabolic diseases in Brazilian populations (2018)
Hirata, Rosario Dominguez Crespo ; Cerda, Alvaro; Genvigir, Fabiana Dalla Vecchia; Hirata, Mario Hiroyuki
Source: Brazilian Journal of Pharmaceutical Sciences. Unidade: FCF
Subjects: DOENÇAS METABÓLICAS, POLIMORFISMO, FARMACOGENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HIRATA, Rosario Dominguez Crespo et al. Pharmacogenetic implications in the management of metabolic diseases in Brazilian populations. Brazilian Journal of Pharmaceutical Sciences, v. 54, p. 1-25 art. e01005, 2018Tradução . . Disponível em: https://doi.org/10.1590/s2175-97902018000001005. Acesso em: 16 jun. 2024.
APA
Hirata, R. D. C., Cerda, A., Genvigir, F. D. V., & Hirata, M. H. (2018). Pharmacogenetic implications in the management of metabolic diseases in Brazilian populations. Brazilian Journal of Pharmaceutical Sciences, 54, 1-25 art. e01005. doi:10.1590/s2175-97902018000001005
NLM
Hirata RDC, Cerda A, Genvigir FDV, Hirata MH. Pharmacogenetic implications in the management of metabolic diseases in Brazilian populations [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2018 ; 54 1-25 art. e01005.[citado 2024 jun. 16 ] Available from: https://doi.org/10.1590/s2175-97902018000001005
Vancouver
Hirata RDC, Cerda A, Genvigir FDV, Hirata MH. Pharmacogenetic implications in the management of metabolic diseases in Brazilian populations [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2018 ; 54 1-25 art. e01005.[citado 2024 jun. 16 ] Available from: https://doi.org/10.1590/s2175-97902018000001005
Trabalho de evento-resumo periodico
Response to cholesterol-lowering therapy is associated with adverse muscular events in patients with familial hypercholesterolemia (2018)
Hernandez, Carolina Dagli; Borges, Jéssica Bassani; Faludi, André Arpad; Gonçalves, Rodrigo Marques; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Source: Brazilian Journal of Pharmaceutical Sciences. Conference titles: Congress of the Brazilian Association of Pharmaceutical Sciences/ABCF. Unidade: FCF
Subjects: ESTATINAS, HIPERCOLESTEROLEMIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HERNANDEZ, Carolina Dagli et al. Response to cholesterol-lowering therapy is associated with adverse muscular events in patients with familial hypercholesterolemia. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. Disponível em: http://www.ivabcfcongress.com.br/arquivos/trabalhos-cientificos.pdf. Acesso em: 16 jun. 2024. , 2018
APA
Hernandez, C. D., Borges, J. B., Faludi, A. A., Gonçalves, R. M., Hirata, M. H., & Hirata, R. D. C. (2018). Response to cholesterol-lowering therapy is associated with adverse muscular events in patients with familial hypercholesterolemia. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. Recuperado de http://www.ivabcfcongress.com.br/arquivos/trabalhos-cientificos.pdf
NLM
Hernandez CD, Borges JB, Faludi AA, Gonçalves RM, Hirata MH, Hirata RDC. Response to cholesterol-lowering therapy is associated with adverse muscular events in patients with familial hypercholesterolemia [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2018 ; 54 222 res. 423.[citado 2024 jun. 16 ] Available from: http://www.ivabcfcongress.com.br/arquivos/trabalhos-cientificos.pdf
Vancouver
Hernandez CD, Borges JB, Faludi AA, Gonçalves RM, Hirata MH, Hirata RDC. Response to cholesterol-lowering therapy is associated with adverse muscular events in patients with familial hypercholesterolemia [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2018 ; 54 222 res. 423.[citado 2024 jun. 16 ] Available from: http://www.ivabcfcongress.com.br/arquivos/trabalhos-cientificos.pdf
Artigo de periodico
Relationship between glycemic control and OPG gene polymorphisms with lower bone mineral density in patients with type 1 Diabetes mellitus (2017)
Loureiro, Melina Bezerra; Ururahy, Marcela Abbott Galvão; Souza, Karla Simone Costa de; Oliveira, Yonara Monique da Costa; Silva, Heglayne Pereira Vital da; Bortolin, Raul Hernandes; Bezerra, João Felipe; Hirata, Rosario Dominguez Crespo ; Maciel Neto, José Jorge; Arrais, Ricardo Fernando; Almeida, Maria das Graças; Hirata, Mario Hiroyuki ; Rezende, Adriana Augusto de
Source: Brazilian Journal of Pharmaceutical Sciences. Unidade: FCF
Subjects: GLICEMIA, DIABETES MELLITUS INSULINO-DEPENDENTE, BIOMARCADORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LOUREIRO, Melina Bezerra et al. Relationship between glycemic control and OPG gene polymorphisms with lower bone mineral density in patients with type 1 Diabetes mellitus. Brazilian Journal of Pharmaceutical Sciences, v. 53, n. 4, p. 1-8 art. e00060, 2017Tradução . . Disponível em: https://doi.org/10.1590/s2175-97902017000400060. Acesso em: 16 jun. 2024.
APA
Loureiro, M. B., Ururahy, M. A. G., Souza, K. S. C. de, Oliveira, Y. M. da C., Silva, H. P. V. da, Bortolin, R. H., et al. (2017). Relationship between glycemic control and OPG gene polymorphisms with lower bone mineral density in patients with type 1 Diabetes mellitus. Brazilian Journal of Pharmaceutical Sciences, 53( 4), 1-8 art. e00060. doi:10.1590/s2175-97902017000400060
NLM
Loureiro MB, Ururahy MAG, Souza KSC de, Oliveira YM da C, Silva HPV da, Bortolin RH, Bezerra JF, Hirata RDC, Maciel Neto JJ, Arrais RF, Almeida M das G, Hirata MH, Rezende AA de. Relationship between glycemic control and OPG gene polymorphisms with lower bone mineral density in patients with type 1 Diabetes mellitus [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2017 ; 53( 4): 1-8 art. e00060.[citado 2024 jun. 16 ] Available from: https://doi.org/10.1590/s2175-97902017000400060
Vancouver
Loureiro MB, Ururahy MAG, Souza KSC de, Oliveira YM da C, Silva HPV da, Bortolin RH, Bezerra JF, Hirata RDC, Maciel Neto JJ, Arrais RF, Almeida M das G, Hirata MH, Rezende AA de. Relationship between glycemic control and OPG gene polymorphisms with lower bone mineral density in patients with type 1 Diabetes mellitus [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2017 ; 53( 4): 1-8 art. e00060.[citado 2024 jun. 16 ] Available from: https://doi.org/10.1590/s2175-97902017000400060
Artigo de periodico
Exposure to potentially inappropriate medications in Brazilian elderly outpatients with metabolic diseases (2016)
Martins, Vanessa dos Santos; Mori, Ana Luiza Pereira Moreira; Dórea, Egídio Lima; Pinto, Gelba Almeida; Hirata, Mario Hiroyuki ; Hirata, Felipe Dominguez Crespo; Hirata, Rosario Dominguez Crespo
Source: Brazilian Journal of Pharmaceutical Sciences. Unidades: FCF, HU
Subjects: DOENÇAS METABÓLICAS, FARMACOTERAPIA, IDOSOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARTINS, Vanessa dos Santos et al. Exposure to potentially inappropriate medications in Brazilian elderly outpatients with metabolic diseases. Brazilian Journal of Pharmaceutical Sciences, v. 52, n. 4, p. 699-707, 2016Tradução . . Disponível em: https://doi.org/10.1590/s1984-82502016000400014. Acesso em: 16 jun. 2024.
APA
Martins, V. dos S., Mori, A. L. P. M., Dórea, E. L., Pinto, G. A., Hirata, M. H., Hirata, F. D. C., & Hirata, R. D. C. (2016). Exposure to potentially inappropriate medications in Brazilian elderly outpatients with metabolic diseases. Brazilian Journal of Pharmaceutical Sciences, 52( 4), 699-707. doi:10.1590/s1984-82502016000400014
NLM
Martins V dos S, Mori ALPM, Dórea EL, Pinto GA, Hirata MH, Hirata FDC, Hirata RDC. Exposure to potentially inappropriate medications in Brazilian elderly outpatients with metabolic diseases [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2016 ; 52( 4): 699-707.[citado 2024 jun. 16 ] Available from: https://doi.org/10.1590/s1984-82502016000400014
Vancouver
Martins V dos S, Mori ALPM, Dórea EL, Pinto GA, Hirata MH, Hirata FDC, Hirata RDC. Exposure to potentially inappropriate medications in Brazilian elderly outpatients with metabolic diseases [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2016 ; 52( 4): 699-707.[citado 2024 jun. 16 ] Available from: https://doi.org/10.1590/s1984-82502016000400014
Trabalho de evento-resumo periodico
SLCO1B1 polymorphisms influence tacrolimus exposure in kidney transplant recipients (2016)
Koyama, Patrícia Tiemi; Campos-Salazar, Antony Brayan; Giuliani, Luccas; Dietzius, Andreia; Genvigir, Fabiana Dalla Vecchia; Bonezi, Vivian; Felipe, Claudia Rosso; Tedesco-Silva Jr, Helio; Medina-Pestana, José Osmar; Fajardo, Cristina Moreno ; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Source: Brazilian Journal of Pharmaceutical Sciences. Conference titles: Pharmaceutical Sciences and Technology Meeting of the Faculty of Pharmaceutical Sciences, University of São Paulo. Unidade: FCF
Assunto: POLIMORFISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KOYAMA, Patrícia Tiemi et al. SLCO1B1 polymorphisms influence tacrolimus exposure in kidney transplant recipients. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 16 jun. 2024. , 2016
APA
Koyama, P. T., Campos-Salazar, A. B., Giuliani, L., Dietzius, A., Genvigir, F. D. V., Bonezi, V., et al. (2016). SLCO1B1 polymorphisms influence tacrolimus exposure in kidney transplant recipients. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Koyama PT, Campos-Salazar AB, Giuliani L, Dietzius A, Genvigir FDV, Bonezi V, Felipe CR, Tedesco-Silva Jr H, Medina-Pestana JO, Fajardo CM, Hirata MH, Hirata RDC. SLCO1B1 polymorphisms influence tacrolimus exposure in kidney transplant recipients. Brazilian Journal of Pharmaceutical Sciences. 2016 ; 52 50 res. FCF095.[citado 2024 jun. 16 ]
Vancouver
Koyama PT, Campos-Salazar AB, Giuliani L, Dietzius A, Genvigir FDV, Bonezi V, Felipe CR, Tedesco-Silva Jr H, Medina-Pestana JO, Fajardo CM, Hirata MH, Hirata RDC. SLCO1B1 polymorphisms influence tacrolimus exposure in kidney transplant recipients. Brazilian Journal of Pharmaceutical Sciences. 2016 ; 52 50 res. FCF095.[citado 2024 jun. 16 ]
Artigo de periodico-resenha
Resenha sem título próprio (2015)
Hirata, Mario Hiroyuki
Source: Brazilian Journal of Pharmaceutical Sciences. Unidade: FCF
Assunto: PROTEÍNAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HIRATA, Mario Hiroyuki. Resenha sem título próprio. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 16 jun. 2024. , 2015
APA
Hirata, M. H. (2015). Resenha sem título próprio. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Hirata MH. Resenha sem título próprio. Brazilian Journal of Pharmaceutical Sciences. 2015 ; 51( 1): 252-253.[citado 2024 jun. 16 ]
Vancouver
Hirata MH. Resenha sem título próprio. Brazilian Journal of Pharmaceutical Sciences. 2015 ; 51( 1): 252-253.[citado 2024 jun. 16 ]
Trabalho de evento-resumo periodico
Influence of CYP3A5 and PPP3CA polymorphisms on tracrolimus response in the brazilian kidney transplant recipients (2015)
Salgado, Patricia de Cássia; Genvigir, Fabiana Dalla Vecchia; Cerda, Alvaro; Bonezi, Vivian; Felipe, Claudia Rosso; Silva Junior, Helio Tedesco; Oliveira, Nagila; Pestana, Jose Osmar Medina; Doi, Sonia de Quateli; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Source: Brazilian Journal of Pharmaceutical Sciences. Conference titles: Pharmaceutical Congress of São Paulo. Unidade: FCF
Subjects: POLIMORFISMO, TRANSPLANTE DE RIM
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SALGADO, Patricia de Cássia et al. Influence of CYP3A5 and PPP3CA polymorphisms on tracrolimus response in the brazilian kidney transplant recipients. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 16 jun. 2024. , 2015
APA
Salgado, P. de C., Genvigir, F. D. V., Cerda, A., Bonezi, V., Felipe, C. R., Silva Junior, H. T., et al. (2015). Influence of CYP3A5 and PPP3CA polymorphisms on tracrolimus response in the brazilian kidney transplant recipients. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Salgado P de C, Genvigir FDV, Cerda A, Bonezi V, Felipe CR, Silva Junior HT, Oliveira N, Pestana JOM, Doi S de Q, Hirata MH, Hirata RDC. Influence of CYP3A5 and PPP3CA polymorphisms on tracrolimus response in the brazilian kidney transplant recipients. Brazilian Journal of Pharmaceutical Sciences. 2015 ; 51 109 res. CPF213.[citado 2024 jun. 16 ]
Vancouver
Salgado P de C, Genvigir FDV, Cerda A, Bonezi V, Felipe CR, Silva Junior HT, Oliveira N, Pestana JOM, Doi S de Q, Hirata MH, Hirata RDC. Influence of CYP3A5 and PPP3CA polymorphisms on tracrolimus response in the brazilian kidney transplant recipients. Brazilian Journal of Pharmaceutical Sciences. 2015 ; 51 109 res. CPF213.[citado 2024 jun. 16 ]
Trabalho de evento-resumo periodico
Association of PPP3CA, FKBP5 and FKBP1B MRNA expression in leucocytes with tacrolimus blood levels in kidney transplant recipients (2015)
Bonezi, Vivian; Salgado, Patricia de Cássia; Cerda, Alvaro; Hirata, Mario Hiroyuki ; Felipe, Claudia Rosso; Oliveira, Nagila; Silva Junior, Helio Tedesco; Pestana, José Osmar Medina; Fajardo, Cristina Moreno ; Genvigir, Fabiana Dalla Vecchia; Doi, Sonia de Quateli; Hirata, Rosario Dominguez Crespo
Source: Brazilian Journal of Pharmaceutical Sciences. Conference titles: Pharmaceutical Congress of São Paulo. Unidade: FCF
Subjects: LEUCÓCITOS, EXPRESSÃO GÊNICA, TRANSPLANTE DE RIM
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BONEZI, Vivian et al. Association of PPP3CA, FKBP5 and FKBP1B MRNA expression in leucocytes with tacrolimus blood levels in kidney transplant recipients. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 16 jun. 2024. , 2015
APA
Bonezi, V., Salgado, P. de C., Cerda, A., Hirata, M. H., Felipe, C. R., Oliveira, N., et al. (2015). Association of PPP3CA, FKBP5 and FKBP1B MRNA expression in leucocytes with tacrolimus blood levels in kidney transplant recipients. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Bonezi V, Salgado P de C, Cerda A, Hirata MH, Felipe CR, Oliveira N, Silva Junior HT, Pestana JOM, Fajardo CM, Genvigir FDV, Doi S de Q, Hirata RDC. Association of PPP3CA, FKBP5 and FKBP1B MRNA expression in leucocytes with tacrolimus blood levels in kidney transplant recipients. Brazilian Journal of Pharmaceutical Sciences. 2015 ; 51 104 res. CPF204.[citado 2024 jun. 16 ]
Vancouver
Bonezi V, Salgado P de C, Cerda A, Hirata MH, Felipe CR, Oliveira N, Silva Junior HT, Pestana JOM, Fajardo CM, Genvigir FDV, Doi S de Q, Hirata RDC. Association of PPP3CA, FKBP5 and FKBP1B MRNA expression in leucocytes with tacrolimus blood levels in kidney transplant recipients. Brazilian Journal of Pharmaceutical Sciences. 2015 ; 51 104 res. CPF204.[citado 2024 jun. 16 ]
Trabalho de evento-resumo periodico
Hypertrophic cardiomyopathy: novel variants in MYH7, MYBPC3 and TNNT2 (2015)
Bastos, Gisele Medeiros; Souza, Diane Dutra; Germano, Juliana de Freitas; Saldarriaga, Magda Elizabeth Graciano; Mori, Augusto Akira; Fajardo, Cristina Moreno ; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki
Source: Brazilian Journal of Pharmaceutical Sciences. Conference titles: Pharmaceutical Congress of São Paulo. Unidade: FCF
Assunto: DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BASTOS, Gisele Medeiros et al. Hypertrophic cardiomyopathy: novel variants in MYH7, MYBPC3 and TNNT2. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 16 jun. 2024. , 2015
APA
Bastos, G. M., Souza, D. D., Germano, J. de F., Saldarriaga, M. E. G., Mori, A. A., Fajardo, C. M., et al. (2015). Hypertrophic cardiomyopathy: novel variants in MYH7, MYBPC3 and TNNT2. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Bastos GM, Souza DD, Germano J de F, Saldarriaga MEG, Mori AA, Fajardo CM, Hirata RDC, Hirata MH. Hypertrophic cardiomyopathy: novel variants in MYH7, MYBPC3 and TNNT2. Brazilian Journal of Pharmaceutical Sciences. 2015 ; 51 108 res. CPF211.[citado 2024 jun. 16 ]
Vancouver
Bastos GM, Souza DD, Germano J de F, Saldarriaga MEG, Mori AA, Fajardo CM, Hirata RDC, Hirata MH. Hypertrophic cardiomyopathy: novel variants in MYH7, MYBPC3 and TNNT2. Brazilian Journal of Pharmaceutical Sciences. 2015 ; 51 108 res. CPF211.[citado 2024 jun. 16 ]
Trabalho de evento-resumo periodico
Pcr product (linear pcr amplicom) and plasmid standar (2012)
Gonzaga, Vuvian Fonseca; Lopes, Tatiana; Marques, Daniela de Araújo Viana; Molino, João Vitor Dutra; Silva, Joás Lucas da; Hirata, Mario Hiroyuki ; Mazzola, Priscila Gava; Gatti, Maria Silvia; Pessoa Junior, Adalberto
Source: Brazilian Journal of Pharmaceutical Sciences. Conference titles: Pharmaceutical Science and Technology Meeting. Unidade: FCF
Subjects: REAÇÃO EM CADEIA POR POLIMERASE, GENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GONZAGA, Vuvian Fonseca et al. Pcr product (linear pcr amplicom) and plasmid standar. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 16 jun. 2024. , 2012
APA
Gonzaga, V. F., Lopes, T., Marques, D. de A. V., Molino, J. V. D., Silva, J. L. da, Hirata, M. H., et al. (2012). Pcr product (linear pcr amplicom) and plasmid standar. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Gonzaga VF, Lopes T, Marques D de AV, Molino JVD, Silva JL da, Hirata MH, Mazzola PG, Gatti MS, Pessoa Junior A. Pcr product (linear pcr amplicom) and plasmid standar. Brazilian Journal of Pharmaceutical Sciences. 2012 ; 48 25 res. FCF046 .[citado 2024 jun. 16 ]
Vancouver
Gonzaga VF, Lopes T, Marques D de AV, Molino JVD, Silva JL da, Hirata MH, Mazzola PG, Gatti MS, Pessoa Junior A. Pcr product (linear pcr amplicom) and plasmid standar. Brazilian Journal of Pharmaceutical Sciences. 2012 ; 48 25 res. FCF046 .[citado 2024 jun. 16 ]
Trabalho de evento-resumo periodico
Comparison of ct and cy0 methods for quantitative pcr (2012)
Molino, João Vitor Dutra; Lopes, Tatiana; Marques, Daniela de Araújo Viana; Gonzaga, Vuvian Fonseca; Silva, Joás Lucas da; Hirata, Mario Hiroyuki ; Mazzola, Priscila Gava; Gatti, Maria Silvia; Pessoa Junior, Adalberto
Source: Brazilian Journal of Pharmaceutical Sciences. Conference titles: Pharmaceutical Science and Technology Meeting. Unidade: FCF
Subjects: REAÇÃO EM CADEIA POR POLIMERASE, BIOQUÍMICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MOLINO, João Vitor Dutra et al. Comparison of ct and cy0 methods for quantitative pcr. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 16 jun. 2024. , 2012
APA
Molino, J. V. D., Lopes, T., Marques, D. de A. V., Gonzaga, V. F., Silva, J. L. da, Hirata, M. H., et al. (2012). Comparison of ct and cy0 methods for quantitative pcr. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Molino JVD, Lopes T, Marques D de AV, Gonzaga VF, Silva JL da, Hirata MH, Mazzola PG, Gatti MS, Pessoa Junior A. Comparison of ct and cy0 methods for quantitative pcr. Brazilian Journal of Pharmaceutical Sciences. 2012 ; 48 26 res. FCF047.[citado 2024 jun. 16 ]
Vancouver
Molino JVD, Lopes T, Marques D de AV, Gonzaga VF, Silva JL da, Hirata MH, Mazzola PG, Gatti MS, Pessoa Junior A. Comparison of ct and cy0 methods for quantitative pcr. Brazilian Journal of Pharmaceutical Sciences. 2012 ; 48 26 res. FCF047.[citado 2024 jun. 16 ]
Artigo de periodico-resenha
Resenha sem título próprio (2012)
Hirata, Mario Hiroyuki
Source: Brazilian Journal of Pharmaceutical Sciences. Unidade: FCF
Assunto: BIOQUÍMICA CLÍNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HIRATA, Mario Hiroyuki. Resenha sem título próprio. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 16 jun. 2024. , 2012
APA
Hirata, M. H. (2012). Resenha sem título próprio. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Hirata MH. Resenha sem título próprio. Brazilian Journal of Pharmaceutical Sciences. 2012 ; 48( 4): 830.[citado 2024 jun. 16 ]
Vancouver
Hirata MH. Resenha sem título próprio. Brazilian Journal of Pharmaceutical Sciences. 2012 ; 48( 4): 830.[citado 2024 jun. 16 ]
Trabalho de evento-resumo periodico
Imatinib response is influenced by abc and slc transporters polymorphisms in chronic myeloid leukemia patients (2012)
Boacnin, Marina do Rosário; Bueno, Carolina Tosin; Lima, Luciene Terezinha de; Vivona, Douglas; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki ; Ducati, André; Zanichelli, Luchessi Maria Aparecida; Chittone, Carlos Sergio; Guerra-Shinohara, Elvira Maria
Source: Brazilian Journal of Pharmaceutical Sciences. Conference titles: Pharmaceutical Science and Technology Meeting. Unidade: FCF
Subjects: POLIMORFISMO, LEUCEMIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BOACNIN, Marina do Rosário et al. Imatinib response is influenced by abc and slc transporters polymorphisms in chronic myeloid leukemia patients. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 16 jun. 2024. , 2012
APA
Boacnin, M. do R., Bueno, C. T., Lima, L. T. de, Vivona, D., Hirata, R. D. C., Hirata, M. H., et al. (2012). Imatinib response is influenced by abc and slc transporters polymorphisms in chronic myeloid leukemia patients. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Boacnin M do R, Bueno CT, Lima LT de, Vivona D, Hirata RDC, Hirata MH, Ducati A, Zanichelli LMA, Chittone CS, Guerra-Shinohara EM. Imatinib response is influenced by abc and slc transporters polymorphisms in chronic myeloid leukemia patients. Brazilian Journal of Pharmaceutical Sciences. 2012 ; 48 88 res. FCF172.[citado 2024 jun. 16 ]
Vancouver
Boacnin M do R, Bueno CT, Lima LT de, Vivona D, Hirata RDC, Hirata MH, Ducati A, Zanichelli LMA, Chittone CS, Guerra-Shinohara EM. Imatinib response is influenced by abc and slc transporters polymorphisms in chronic myeloid leukemia patients. Brazilian Journal of Pharmaceutical Sciences. 2012 ; 48 88 res. FCF172.[citado 2024 jun. 16 ]

USP Schools

ReP

Filtros

Departament

Authors

USP affiliated authors

Date published

Subjects

Conference titles

Grupo de pesquisa

Funding Agencies

Normalized affiliation

Non normalized affiliation